← European Medicine Shortage Tracker · all medicines

Pasireotide recordati rare diseases, france shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Pasireotide recordati rare diseases, france currently has availability issues reported in 1 European register: Greece.

Limited availability  ATC H01CB05 · also listed as: PASIREOTIDE RECORDATI RARE DISEASES, FRANCE · data refreshed 11 September 2026

Key facts

As of 11 September 2026, 1 of the 9 tracked registers list current availability issues for Pasireotide recordati rare diseases, france, covering 1 affected product presentation. The longest-running open report was filed in Greece on 2026-06-11 and has now been open for about 3 months. Where agencies state a cause, delivery delays lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. In the WHO ATC classification, Pasireotide recordati rare diseases, france is coded H01CB05 — a medicine acting on systemic hormonal preparations — so clinically related products appear under “Related medicines” below.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇬🇷 GreeceLimited availability
2ML SOLV + INJECTION KIT
2026-06-112026-07-10Καθυστέρηση παράδοσης Εναλλακτικά το ίδιο σκεύασμα σε διαφορετική περιregister ↗

Full report history (1 register entry)

Every individual register entry for Pasireotide recordati rare diseases, france in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇬🇷 GR2ML SOLV + INJECTION KITLimited availability2026-06-112026-07-10Καθυστέρηση παράδοσης Εναλλακτικά το ίδιο σκεύασμα σε διαφορ

Frequently asked

Is Pasireotide recordati rare diseases, france currently in shortage in Europe?

Yes. As of 11 September 2026, availability issues are reported in: Greece. Availability is national — a shortage in one country does not mean it is short everywhere.

Where does this Pasireotide recordati rare diseases, france availability data come from?

Directly from the official medicines-agency register that lists Pasireotide recordati rare diseases, france: EOF limited-availability list (Greece). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Related medicines (same ATC class)

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Pasireotide recordati rare diseases, france — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pasireotide-recordati-rare-diseases-france/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Pasireotide recordati rare diseases, france availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/pasireotide-recordati-rare-diseases-france/">Pasireotide recordati rare diseases, france shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Pasireotide recordati rare diseases, france: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 11 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.